De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents

Gabriela Kuftinec1 Department of Internal Medicine,University of California Davis, 4150 V St, PSSB 3100, Sacramento, CA 95817, USAView further author information

Thomas Loehfelm2 Department of Radiology,University of California Davis, 4860 Y Street, Suite 3100, Sacramento, CA 95817, USAView further author information

Michael Corwin2 Department of Radiology,University of California Davis, 4860 Y Street, Suite 3100, Sacramento, CA 95817, USAView further author information

Blythe Durbin-Johnson3 Division of Biostatistics,University of California Davis, Genome and Biomedical Sciences Facility, 451 Health Sciences Dr., Rm. 1300, Davis, CA 95616, USAView further author information

MarieChristi Candido4 Division of Gastroenterology & Hepatology,University of California Davis, 4150 V St, PSSB 3500, Sacramento, CA 95817, USAView further author information

Rebecca Hluhanich5 Hepatology & Infectious Diseases Specialty Pharmacy,University of California Davis Health, 2315 Stockton Blvd, Sacramento, CA 95817, USACorrespondence[email protected]
View further author information

Souvik Sarkar4 Division of Gastroenterology & Hepatology,University of California Davis, 4150 V St, PSSB 3500, Sacramento, CA 95817, USACorrespondence[email protected]
View further author information

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.